• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The role and impact of cost-sharing mechanisms for prescription drug coverage.

作者信息

Gagnon Marc-André

机构信息

School of Public Policy and Administration, Carleton University, Ottawa, Ont.

出版信息

CMAJ. 2017 May 15;189(19):E680-E681. doi: 10.1503/cmaj.170169.

DOI:10.1503/cmaj.170169
PMID:28507086
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5433868/
Abstract
摘要

相似文献

1
The role and impact of cost-sharing mechanisms for prescription drug coverage.处方药保险费用分摊机制的作用与影响。
CMAJ. 2017 May 15;189(19):E680-E681. doi: 10.1503/cmaj.170169.
2
Impact of cost sharing on prescription drugs used by Medicare beneficiaries.医疗保险受益人的处方药费用分担的影响。
Res Social Adm Pharm. 2010 Jun;6(2):100-9. doi: 10.1016/j.sapharm.2010.03.003. Epub 2010 May 7.
3
Controlling spending for prescription drugs.控制处方药支出。
N Engl J Med. 2002 Mar 14;346(11):855-6. doi: 10.1056/NEJM200203143461113.
4
Pharmaceuticals and medical devices: Medicare Part D. End-of-year issue brief.药品和医疗器械：医疗保险D部分。年终问题简报。
Issue Brief Health Policy Track Serv. 2009 Jan 5:1-26.
5
The effects of copayments and generic substitution on the use and costs of prescription drugs.共付额和通用名药物替代对处方药使用及成本的影响。
Inquiry. 1993 Summer;30(2):189-98.
6
Financial consequences of drug benefit plans.药品福利计划的财务后果。
JAMA. 2003;289(4):423; author reply 424. doi: 10.1001/jama.289.4.423-a.
7
Financial consequences of drug benefit plans.药品福利计划的财务后果。
JAMA. 2003;289(4):423; author reply 424. doi: 10.1001/jama.289.4.423-b.
8
Financial consequences of drug benefit plans.药品福利计划的财务后果。
JAMA. 2003;289(4):423-4; author reply 424. doi: 10.1001/jama.289.4.423-c.
9
The new Medicare prescription-drug legislation.新的医疗保险处方药立法。
N Engl J Med. 2004 Jan 1;350(1):9-10. doi: 10.1056/NEJMp038224.
10
Prescription drug prices in Canada.加拿大的处方药价格。
Issue Brief (Public Policy Inst (Am Assoc Retired Pers)). 2003 Jun(IB62):1-22.

引用本文的文献

1
Enhancing primary care capacity in chronic kidney disease management: a quality improvement educational initiative.提高慢性肾脏病管理中的基层医疗能力：一项质量改进教育计划。
BMJ Open. 2021 Nov 9;11(11):e046068. doi: 10.1136/bmjopen-2020-046068.
2
Cost-related medication nonadherence in Canada: a systematic review of prevalence, predictors, and clinical impact.加拿大与费用相关的药物治疗不依从性：患病率、预测因素及临床影响的系统评价
Syst Rev. 2021 Jan 6;10(1):11. doi: 10.1186/s13643-020-01558-5.
3
Co-pay cards in Canada: Improving choice or institutionalizing bribes?加拿大的共付卡：是改善选择还是使贿赂制度化？
CMAJ. 2019 Nov 11;191(45):E1235-E1236. doi: 10.1503/cmaj.191447.
4
Capacity of Kidney Care in Canada: Identifying Barriers and Opportunities.加拿大肾脏护理能力：识别障碍与机遇
Can J Kidney Health Dis. 2019 Aug 30;6:2054358119870540. doi: 10.1177/2054358119870540. eCollection 2019.

本文引用的文献

1
Impact of income-based deductibles on drug use and health care utilization among older adults.基于收入的免赔额对老年人药物使用和医疗保健利用的影响。
CMAJ. 2017 May 15;189(19):E690-E696. doi: 10.1503/cmaj.161119.
2
The effects of catastrophic drug plan deductibles on older women's use of cardiovascular medicines: a retrospective cohort study.灾难性药物计划免赔额对老年女性心血管药物使用的影响：一项回顾性队列研究。
CMAJ Open. 2017 Mar 3;5(1):E198-E204. doi: 10.9778/cmajo.20160145. eCollection 2017 Jan-Mar.
3
Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.药品政策：封顶价和共付额对合理用药的影响。
Cochrane Database Syst Rev. 2015 May 8;2015(5):CD007017. doi: 10.1002/14651858.CD007017.pub2.
4
Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.药品政策：参考定价、其他定价及采购政策的影响
Cochrane Database Syst Rev. 2014 Oct 16;2014(10):CD005979. doi: 10.1002/14651858.CD005979.pub2.
5
Universal drug coverage and socioeconomic disparities in major diabetes outcomes.全民药物覆盖和主要糖尿病结局的社会经济差异。
Diabetes Care. 2012 Nov;35(11):2257-64. doi: 10.2337/dc12-0364. Epub 2012 Aug 13.
6
The impact of co-payment increases on dispensings of government-subsidised medicines in Australia.澳大利亚自付费用增加对政府补贴药品配药的影响。
Pharmacoepidemiol Drug Saf. 2008 Nov;17(11):1091-9. doi: 10.1002/pds.1670.
7
Severity of illness and the welfare effects of moral hazard.疾病严重程度与道德风险的福利效应。
Int J Health Care Finance Econ. 2006 Dec;6(4):290-9. doi: 10.1007/s10754-006-9006-3. Epub 2006 Nov 30.
8
The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.处方药支出费用分担对老年人医疗保健利用的影响：自价格弹性和交叉价格弹性
Health Policy. 2007 Aug;82(3):340-7. doi: 10.1016/j.healthpol.2006.11.002. Epub 2006 Nov 28.
9
Adverse events associated with prescription drug cost-sharing among poor and elderly persons.贫困和老年人群中与处方药费用分担相关的不良事件。
JAMA. 2001;285(4):421-9. doi: 10.1001/jama.285.4.421.
10
Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.医疗补助计划下处方药的支付限制。对治疗、成本和公平性的影响。
N Engl J Med. 1987 Aug 27;317(9):550-6. doi: 10.1056/NEJM198708273170906.